Vaccine confusion as clots force jab switch for two million

17 June 2021 - Health authorities are scrambling to switch more than two million Australians aged under 60 to the ...

Read more →

Moderna seeks vaccine approval for adolescents

11 June 2021 - US-based biotech company Moderna is applying for the use of its COVID-19 vaccine for adolescents aged 12 ...

Read more →

Uptake of medicines for type 2 diabetes mellitus

15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...

Read more →

Istari Oncology announces FDA granted fast track designation to PVSRIPO for the treatment of advanced melanoma

14 June 2021 - Istari Oncology announced today the U.S. FDA has granted fast track designation to PVSRIPO for the ...

Read more →

Avenue Therapeutics receives complete response letter from the FDA for intravenous tramadol

14 June 2021 - Avenue Therapeutics today announced that it has received a second complete response letter from the U.S. ...

Read more →

Vaxzevria: EMA advises against use in people with history of capillary leak syndrome

11 June 2021 - EMA’s safety committee (PRAC) has concluded that people who have previously had capillary leak syndrome must not ...

Read more →

The FDA still lacks a permanent chief, despite pressing, weighty problems

12 June 2021 - With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing ...

Read more →

Opdivo plus Yervoy scores NICE backing for certain bowel cancer patients

14 June 2021 - Bristol Myers Squibb’s immunotherapy combination Opdivo plus Yervoy has been recommended by NICE for the treatment ...

Read more →

NICE to reassess Kyowa Kirin’s Poteligeo

14 June 2021 - NICE will reassess Kyowa Kirin’s rare blood cancer treatment Poteligeo after upholding an appeal launched by ...

Read more →

Ascendis Pharma announces extension of U.S. FDA review period for TransCon hGH (onapegsomatropin) for paediatric growth hormone deficiency

11 June 2021 - Prescription Drug User Fee Act goal date extended by three months for further review of submission to ...

Read more →

Unaffordable treatment for severe malaria highlights U.S. drug market pitfalls

11 June 2021 - When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the only ...

Read more →

If vaccine apartheid exists, vaccine billionaires shouldn’t

12 June 2021 - To understand why billionaires are a sign of moral and economic failure, look no further than ...

Read more →

Incyte announces U.S. FDA has extended the new drug application review period for ruxolitinib cream for the treatment of atopic dermatitis

11 June 2021 - Incyte announced today that the U.S. FDA has extended the review period for the new drug ...

Read more →

Third member of prestigious FDA panel resigns over approval of Biogen's Alzheimer's drug

10 June 2021 - A third member of a key FDA advisory panel has resigned over the agency's controversial decision to ...

Read more →

Sanofi provides update on Aubagio (teriflunomide) submission for children and adolescents with relapsing-remitting multiple sclerosis in the U.S

11 June 2021 - The U.S. FDA has issued a complete response letter regarding the supplemental new drug application for ...

Read more →

Moderna files for emergency use authorisation for its COVID-19 vaccine in adolescents in the United States

10 June 2021 - Submission based on Phase 2/3 trial of mRNA-1273 in adolescents ages 12 to less than 18 ...

Read more →